Gabapentin
Product Images NDC 42549-537
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 42549-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula (E8695a1d Fd85 4639 81ff Bab10676ebd9 01)
Figure 1 (E8695a1d Fd85 4639 81ff Bab10676ebd9 02)
This appears to be a graph or chart with different doses of a medication (Gabapentin) being tested in a clinical trial. The time frame is divided into a 4 week dose titration period and a 4 week fixed dose period. There is also a placebo group included. It is unclear what the specific outcome measure of the trial is.*
Figure 2 (E8695a1d Fd85 4639 81ff Bab10676ebd9 03)
This is a study report that presents the mean pain score over a 43 week period with 4 weeks of dose titration. The study compares the effects of a placebo, 1800 mg/day Gabapentin, and 2400 mg/day Gabapentin. The results show a statistically significant reduction in pain scores for both doses of Gabapentin compared to placebo. However, the readability of the text might be affected by the quality.*
Figure 3 (E8695a1d Fd85 4639 81ff Bab10676ebd9 04)
Figure 4 (E8695a1d Fd85 4639 81ff Bab10676ebd9 05)
Company Logo (E8695a1d Fd85 4639 81ff Bab10676ebd9 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.